3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Hepatocellular
42
Parkinson Disease 4, Autosomal Dominant Lewy Body
29
Carcinoma, Renal Cell
26
Endometrial Neoplasms
13
Melanoma
10
Neoplasms
8
Cholangiocarcinoma
8
Uterine Cervical Neoplasms
7
Biliary Tract Neoplasms
7
Liver Neoplasms
6
Stomach Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
5
Neuroendocrine Tumors
5
Triple Negative Breast Neoplasms
4
Thyroid Neoplasms
4
Ovarian Neoplasms
4
Neoplasm Metastasis
4
Esophageal Squamous Cell Carcinoma
4
Colorectal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Thyroid Carcinoma, Anaplastic
3
Recurrence
3
Kidney Neoplasms
3
Esophageal Neoplasms
3
Diabetes Mellitus, Insulin-Dependent, 12
3
Cirrhosis, Familial, with Pulmonary Hypertension
3
Carcinoma, Adenoid Cystic
3
Breast Neoplasms
3
Brain Neoplasms
3
Adenocarcinoma
3
Interventions
Injections
20
Carboplatin
9
pembrolizumab
8
Bevacizumab
6
Pemetrexed
5
Paclitaxel
5
Leucovorin
5
Fluorouracil
5
fludarabine
4
Oxaliplatin
4
Docetaxel
4
sotorasib
3
atezolizumab
3
Drug Therapy
3
Cyclophosphamide
3
Capecitabine
3
trifluridine tipiracil drug combination
2
trametinib
2
toripalimab
2
spartalizumab
2
palbociclib
2
olaparib
2
Panitumumab
2
Immune Checkpoint Inhibitors
2
Fulvestrant
2
Etoposide
2
Cisplatin
2
Cetuximab
2
130-nm albumin-bound paclitaxel
2
zimberelimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Advanced Solid Tumors
×
lenvatinib
×
1 year
×
Clear all
No trials found.